CD276 and chronic myelogenous leukemia, BCR-ABL1 positive: For hematologic malignancies, the expression of B7‐H3 is relatively low and more variable, with increased expression in AML compared to other myeloid malignancies like CML and the lymphoid malignancies (Figure 1A).